Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0000950170-25-114033

Chief Accounting Officer sold 150,000 shares at an average $25.83 ($3,874,017)

  • Chief Accounting Officer acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kooij Louise Frederika · Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-09 Exercise or conversion : show line 1 in the form +150,000 $10.00 $1,500,000 165,000 D
2025-09-09 Sale : show line 2 in the form −53,104 $25.31 $1,344,062 111,896 D
2025-09-09 Sale : show line 3 in the form −96,896 $26.11 $2,529,955 15,000 D
Open-market sales · 150,000 sh · avg $25.83 · $3,874,017

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-09 Exercise or conversion : show line 4 in the form Option (right to buy) −150,000 280,015 D
Loading xslF345X05/ownership.xml…